Why do SSRIs cause genital numbness?

SSRIs increase synaptic serotonin, which can desensitise 5-HT1A receptors involved in sexual response and disrupt neuropeptide signalling in genital tissue. In PSSD, a 2022 Finnish study found evidence of small-fiber neuropathy — actual structural damage to sensory nerve fibers — in the genital area of affected patients.

Is SSRI genital numbness permanent?

For most patients, genital numbness during SSRI use resolves after stopping the medication. In PSSD, however, numbness persists after discontinuation. Duration varies widely — from months to years. The 2022 Finnish biopsy study suggesting small-fiber neuropathy raises the possibility that structural nerve damage may contribute to persistence in some patients.

What is the Finnish PSSD biopsy study?

Heikkinen et al. (2022) performed skin punch biopsies on PSSD patients and found reduced intraepidermal nerve fiber density — evidence of small-fiber neuropathy — in genital tissue. This was the first study to provide histological (tissue-level) evidence of a structural peripheral nervous system component in PSSD.

What are people with PSSD trying for genital numbness?

The PSSD community reports trying a range of approaches including psilocybin/microdosing (for its neuroplasticity and 5-HT2A agonism), hormone optimisation, lifestyle interventions, and various supplements. No approach has been validated in clinical trials specifically for PSSD genital numbness.

SSRI Genital Numbness: Why It Happens and What People Are Trying

Genital numbness from SSRIs is the most commonly reported PSSD symptom. A 2022 Finnish biopsy study found structural nerve damage in PSSD patients. Here is what the science says about why it happens.

Direct Answer: SSRI genital numbness occurs because SSRIs chronically elevate serotonin, desensitising 5-HT1A receptors and disrupting neuropeptide signalling in genital tissue. In PSSD, a 2022 Finnish biopsy study found structural small-fiber neuropathy — actual nerve damage — in affected patients, providing the first histological evidence for why numbness can persist after stopping antidepressants.

The Neurological Mechanism of SSRI Genital Numbness

Genital numbness is the most commonly reported symptom of PSSD, affecting over 80% of patients in published surveys. Understanding why it happens requires looking at how SSRIs interact with the nervous system at multiple levels.

5-HT1A Receptor Desensitisation

SSRIs work by blocking the reuptake of serotonin, chronically elevating serotonin levels in synapses throughout the brain and peripheral nervous system. The body responds by downregulating and desensitising serotonin receptors — particularly 5-HT1A autoreceptors, which normally provide negative feedback on serotonin release.

In the sexual response pathway, 5-HT1A receptors in the hypothalamus and spinal cord play a key role in mediating genital sensation and arousal. Desensitisation of these receptors during SSRI treatment blunts sexual response. In most patients, receptor sensitivity normalises after discontinuation. In PSSD, this normalisation appears not to occur — or occurs only partially.

Neuropeptide Disruption

SSRIs affect not only serotonin but also a range of neuropeptides that are critical for sexual function. These include:

Nitric oxide (NO) — essential for vasodilation and genital engorgement. Serotonin inhibits NO synthesis via 5-HT2B receptors.
Oxytocin — involved in arousal and orgasm. Serotonin modulates oxytocin release from the hypothalamus.
Dopamine — the primary driver of sexual motivation and pleasure. Serotonin and dopamine have an inhibitory relationship; elevated serotonin suppresses dopaminergic activity in the mesolimbic pathway.

Chronic disruption of these neuropeptide systems during SSRI treatment may produce lasting changes that persist after discontinuation in PSSD patients.

The Finnish Biopsy Study: Structural Nerve Damage

The most significant recent development in PSSD research is the 2022 study by Heikkinen et al. at the University of Helsinki. The researchers performed skin punch biopsies on PSSD patients and controls, analysing intraepidermal nerve fiber density (IENFD) — a validated measure of small-fiber neuropathy.

Finding	PSSD Patients	Controls	Significance
Reduced IENFD (genital skin)	Significantly reduced	Normal range	First histological evidence of peripheral nerve damage in PSSD
Small-fiber neuropathy diagnosis	Confirmed in subset	Not present	Structural explanation for persistent numbness
Symptom correlation	Numbness severity correlated with IENFD reduction	N/A	Supports causal relationship

This finding is significant because it shifts PSSD from a purely central (brain-based) condition to one with a peripheral nervous system component. Small-fiber neuropathy is a recognised condition with established diagnostic criteria and, in some contexts, treatment approaches — opening new avenues for PSSD research.

What People With PSSD Are Trying

In the absence of approved treatments, people with PSSD genital numbness report exploring a range of approaches through online communities and case reports. These are not medical recommendations — they are documented reports from the PSSD community:

Approach	Proposed Mechanism	Evidence Level	Community Reports
Psilocybin / microdosing	5-HT2A agonism, neuroplasticity, BDNF upregulation	Mechanistic overlap; no PSSD-specific trials	Mixed; some report partial improvement
Hormone optimisation (testosterone, DHEA)	Address secondary hormonal dysregulation	Case reports only	Some report partial improvement
Exercise (aerobic + resistance)	BDNF upregulation, dopamine restoration	Indirect (general neuroplasticity evidence)	Widely reported as helpful for energy/mood
Alpha-lipoic acid, acetyl-L-carnitine	Small-fiber neuropathy support	Evidence for diabetic neuropathy; not PSSD	Anecdotal reports in community

Explore Shrooomz Botanical Supplements

USA-grown. Third-party tested. Formulated for serotonergic health and neuroplasticity support.

View Our Supplements →

Return to the PSSD Resource Hub. Related: What Is PSSD? | Can Psilocybin Help With PSSD? | Natural Approaches to PSSD | PSSD Recovery Research